Overview

Effect of Rifampin on the Pharmacokinetics of BAY73-4506

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if giving rifampin, a marketed antibiotic, changes how your body absorbs and distributes BAY73-4506.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Rifampin